Events

MSCA European Researchers' Night 2020 call - info day through web stream
NOV
Fri
15
09:00 - 10:30

This was 6 years ago

Location

Online


Programmes
MSCA

On 15 November 2019 the info day on the European Researchers’ Night 2020 call takes place. The info day will be web streamed only and be made available from 15 November 10 am onwards through the following link: https://webcast.ec.europa.eu/h2020-msca-night-2020-infoday   

The call for European Researchers' Night proposals is currently open with a call deadline of 9 January 2020 and an indicative budget of €8 million. All information can be found on the MSCA-NIGHT-2020 call page on the Horizon 2020 Funding and Tender Portal.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.